SCHEMBL13459941

SCHEMBL13459941

Cc1cc(N)ccc1-c1cccc2c([N+](=O)[O-])nccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ KMT2A Q03164 6/20 0.38
▸ MAPT P10636 6/20 0.38
▸ MEN1 O00255 5/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ S1PR4 O95977 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ PABPC1 P11940 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ CA12 O43570 3/20 0.36
▸ CA1 P00915 3/20 0.36
▸ CA2 P00918 3/20 0.36
▸ CA9 Q16790 3/20 0.36
▸ DYRK1A Q13627 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459543 0.80 DYRK1A (0.39) ALDH1A1CYP3A4KMT2AMEN1CA12
SCHEMBL5685063 0.70 L3MBTL1 (0.46) ALDH1A1CYP3A4TSHRKMT2AMAPT
SCHEMBL23926509 0.70 ALDH1A1 (0.65) ALDH1A1CYP3A4TSHRRECQLKMT2A
SCHEMBL11819002 0.70 TDP1 (0.64) ALDH1A1KMT2AMAPTMEN1RAB9A
SCHEMBL13459551 0.68 PLAU (0.44) ALDH1A1CYP3A4TSHRKMT2AMAPT
SCHEMBL6652930 0.67 AKR1C3 (0.59) ALDH1A1CYP3A4TSHRRECQLKMT2A
SCHEMBL7088850 0.67 ALDH1A1 (0.45) ALDH1A1CYP3A4TSHRRECQLKMT2A
SCHEMBL8146041 0.66 ALDH1A1 (0.54) ALDH1A1CYP3A4TSHRKMT2AMAPT
SCHEMBL16280579 0.66 ALDH1A1 (0.65) ALDH1A1CYP3A4TSHRRECQLKMT2A
SCHEMBL30839745 0.66 ALDH1A1 (0.65) ALDH1A1CYP3A4TSHRRECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback